ScholarIQanswers from OpenAlex & ORCID
John J.P. Kastelein
ResearcherPublications, citations & collaboration network
John J.P. Kastelein is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does John J.P. Kastelein have?
ScholarIQindexed works
John J.P. Kastelein has 1,126 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does John J.P. Kastelein have?
ScholarIQcitation count
John J.P. Kastelein has 137,790 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of John J.P. Kastelein?
ScholarIQh-index
John J.P. Kastelein has an h-index of 167 in OpenAlex.
What is the i10-index of John J.P. Kastelein?
ScholarIQi10-index
John J.P. Kastelein has an i10-index of 731 in OpenAlex.
What is the ORCID of John J.P. Kastelein?
ScholarIQorcid
The ORCID for John J.P. Kastelein is on the source record.
What is the OpenAlex record for John J.P. Kastelein?
ScholarIQopenalex
The OpenAlex for John J.P. Kastelein is on the source record.
What are the most-cited papers on John J.P. Kastelein?
ScholarIQmost cited works
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Paul M. Ridker, Brendan M. Everett, Tom Thurén, Jean MacFadyen, William H. Chang, Christie M. Ballantyne, Francisco Antônio Helfenstein Fonseca, José Carlos Nicolau, Wolfgang Köenig, Stefan D. Anker, John J.P. Kastelein, Jan H. Cornel, Prem Pais, Daniel Pella, Jacques Genest, Renata Cífková, Alberto Lorenzatti, Tamás Forster, Zhanna Kobalava, L Vida-Simiti, Marcus Flather, Hiroaki Shimokawa, Hisao Ogawa, Mikael Dellborg, Paulo R.F. Rossi, Roland P.T. Troquay, Peter Libby, Robert J. Glynn
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease
Cardiogenics, Heribert Schunkert, Inke R. König, Sekar Kathiresan, Muredach P. Reilly, Themistocles L. Assimes, Hilma Hólm, Michael Preuß, Alexandre F.R. Stewart, Maja Barbalić, Christian Gieger, Devin Absher, Zouhair Aherrahrou, Hooman Allayee, David Altshuler, Sonia S. Anand, Karl Andersen, Jeffrey L. Anderson, Diego Ardissino, Stephen G. Ball, Anthony J. Balmforth, Timothy Barnes, Diane M. Becker, Lewis C. Becker, Klaus Berger, Joshua C Bis, S. Matthijs Boekholdt, Eric Boerwinkle, Peter S. Braund, Morris J Brown, Mary Susan Burnett, Ian Buysschaert, John F. Carlquist, Li Chen, Sven Cichon, Veryan Codd, R. W. Davies, George Dedoussis, Abbas Dehghan, Serkalem Demissie, Joseph M. Devaney, Patrick Diemert, Ron Do, Angela Doering, Sandra Eifert, Nour Eddine El Mokhtari, Stephen G. Ellis, Roberto Elosúa, James C. Engert, Stephen E. Epstein, Ulf dé Fairé, Marcus Fischer, Aaron R. Folsom, Jennifer Freyer, Bruna Gigante, Domenico Girelli, Sólveig Grétarsdóttir, Vilmundur Guðnason, Jeffrey R. Gulcher, Eran Halperin, Naomi Hammond, Stanley L. Hazen, Albert Hofman, Benjamin D. Horne, Thomas Illig, Carlos Iribarren, Gregory T. Jones, J. Wouter Jukema, Michael Kaiser, Lee M. Kaplan, John J.P. Kastelein, Kay‐Tee Khaw, Joshua W. Knowles, Genovefa Kolovou, Augustine Kong, Reijo Laaksonen, Diether Lambrechts, Karin Leander, Guillaume Lettre, Mingyao Li, Wolfgang Lieb, Christina Loley, Andrew Lotery, Pier Mannuccio Mannucci, Seraya Maouche, Nicola Martinelli, Pascal McKeown, Christa Meisinger, Thomas Meitinger, Olle Melander, Pier Angelica Merlini, Vincent Mooser, Thomas M. Morgan, Thomas W Mühleisen, Joseph B. Muhlestein, Thomas Münzel, Kiran Musunuru, Janja Nahrstaedt, Christopher P. Nelson, Markus M. Nöthen
Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
Kausik K. Ray, R. Scott Wright, David Kallend, Wolfgang Köenig, Lawrence A. Leiter, Frederick J. Raal, Jenna A. Bisch, Tara Richardson, Mark Jaros, Peter Wijngaard, John J.P. Kastelein
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
Paul M. Ridker, Jean MacFadyen, Tom Thurén, Brendan M Everett, Peter Libby, Robert J. Glynn, Paul M. Ridker, Alberto Lorenzatti, Henry Krum, George Varigos, Peter Siostrzonek, Peter Sinnaeve, Francisco Antônio Helfenstein Fonseca, José Carlos Nicolau, Nina Gotcheva, Jacques Genest, Yong Huo, Miguel Urina‐Triana, Davor Miličić, Renata Cífková, Riina Vettus, Wolfgang Köenig, S.D. Anker, Athanasios Manolis, Fernando Wyss, Tamás Forster, Axel F. Sigurðsson, Prem Pais, Alessandro Fucili, Hisao Ogawa, Hiroaki Shimokawa, Irina Veze, Birutė Petrauskienė, Leon Salvador, John J.P. Kastelein, Jan H. Cornel, Tor Ole Klemsdal, Félix Medina, Andrzej Budaj, L Vida-Simiti, Zhanna Kobalava, Petar Otašević, Daniel Pella, Mitja Lainščak, Ki‐Bae Seung, Patrick Commerford, Mikael Dellborg, Marc Y. Donath, Juey‐Jen Hwang, Hakan Kültürsay, Marcus Flather, Christie M. Ballantyne, Seth Bilazarian, William H. Chang, Cara East, Brendan Everett, Les B. Forgosh, Robert J. Glynn, Barry Harris, Peter Libby, M Ligueros, Tom Thurén, Erin A. Bohula, Bindu Charmarthi, Susan Cheng, Sherry Chou, Jacqueline Suk Danik, Graham T. McMahon, Bradley A. Maron, MingMing Ning, Benjamin A. Olenchock, Reena L. Pande, Todd S. Perlstein, Aruna D. Pradhan, Natalia S. Rost, Aneesh B. Singhal, Viviany R. Taqueti, Nancy Wei, Howard A. Burris, Angela Cioffi, Anne Marie Dalseg, Nilanjan Ghosh, Julie R. Gralow, Tina Mayer, Hope S. Rugo, Vance G. Fowler, Ajit P. Limaye, Sara E. Cosgrove, Donald P. Levine, Renato D. Lópes, John Scott, Tom Thurén, M Ligueros, Robert Hilkert, Georgia Tamesby, Carolyn Mickel, Brian Manning, Julian Woelcke, Monique Tan, S Manfreda
Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
John J.P. Kastelein, Fatima Akdim, Erik S.G. Stroes, Aeilko H. Zwinderman, Michiel L. Bots, Anton F. H. Stalenhoef, Frank L.J. Visseren, Eric J.G. Sijbrands, Mieke D. Trip, Evan A. Stein, Daniel Gaudet, Raphaël Duivenvoorden, Enrico P. Veltri, Adéle Marais, Eric de Groot